Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
PMID: 41155596 Int Immunopharmacol CGRP alleviates epilepsy via JAK1-STAT1-P2RX7 signaling: a novel neuroprotective axis targeting neuronal damage
50 & Target [1] In Vitro SLU-PP-332 (0-5 M, 24 h) increases the expression of an ERR target gene and enhances mitochondrial respiration in C2C12 myocytes [1]
10.3390/cancers14235905 94 ZoufalV.MairingerS.KrohnM.WanekT.FilipT.SaubererM.et al (2019)
The article says improvement in bloating or fluid retention is more pronounced in individuals with baseline metabolic syndrome, hypertension, or insulin resistance, because the benefit runs through metabolic correction
Individual needs vary, and working with a qualified healthcare provider is essential for determining appropriate approaches
US$ 22.79
US$ 24.58
US$ 21.39
US$ 27.04
US$ 27.85
